NEWSFLOW

Oxford BioDynamics (#OBD) – raises further £543,577 at 11p per share via PrimaryBid

NEWSFLOW

Oxford BioDynamics (#OBD) – £5.6m equity raise at 11p per share, with also a PrimaryBid offer

views

Oxford BioDynamics – interims, funding outlook ‘as was the case at the previous period end’… but what about the already-raised net £8.5m since then?!

Describing itself as “a biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform”, Oxford BioDynamics (OBD) has announced results for its half-year ended 31st March 2023 emphasising “excellent progress across the business. There was sustained growth in orders of EpiSwitch CiRT tests, which has continued post-period end. Overwhelming demand for the PSE blood test after announcement of its high accuracy performance”. So what of a current share price response towards 13p, down approaching 22%?!

NEWSFLOW

Oxford BioDynamics (#OBD) – China partnership, including £9.75m of new equity at 208p